An irregular heart rhythm, or atrial fibrillation, was significantly associated
with ischaemic stroke in all regions, but was of greater importance in Western Europe, North America and Australia, than in China or South Asia.
Not exact matches
The findings show just how important it is for people
with acute
ischaemic stroke (in which blood flow to an area of the brain is blocked or reduced) to be identified quickly and treated by specialist staff in order to reduce the subsequent degree of disability.
This compares
with complete recovery for one in five people and death in one in five after an
ischaemic stroke.
Use of oral anticoagulants was associated
with a lower risk of
ischaemic stroke (HR 0.78, 95 % CI 0.63 - 0.97, p = 0.027).
The objective of this study was to assess the incidence and predictors of
ischaemic stroke among low risk patients
with non-valvular AF.
In the multivariable analysis, the only variables that remained significantly associated
with an increased risk of
ischaemic stroke were age (hazard ratio [HR] 1.06, 95 % confidence interval [CI] 1.05 - 1.08, p < 0.001 per incremental year) and alcohol related hospitalisation (HR 2.01, 95 % CI 1.45 — 2.79, p < 0.001).
Among the 50 trials, 30 were primary prevention trials (general populations, smokers and workers exposed to asbestos, patients
with oesophageal dysplasia, male physicians, patients
with non-melanoma skin cancer, postmenopausal women, patients undergoing chronic haemodialysis, patients
with end stage renal disease, ambulatory elderly women
with vitamin D insufficiency, patients
with chronic renal failure, older people
with femoral neck fractures, patients
with diabetes mellitus, elderly women
with a low serum 25 - hydroxyvitamin D concentration, health professionals, people
with a high fasting plasma total homocysteine concentration, or kidney transplant recipients), and 20 were secondary prevention trials (patients
with cardiovascular disease, coronary heart disease, acute myocardial infarction, unstable angina, transient
ischaemic attack,
stroke, angiographically proved coronary atherosclerosis, vascular disease, or aortic valve stenosis).
We also performed subgroup meta - analyses by type of prevention (primary v secondary: in this study, trials involving healthy populations or patients
with any specific disease except for cardiovascular disease were classified as primary prevention trials, and trials involving patients
with cardiovascular disease were classified as secondary prevention trials), type of supplement by quality and dose (each supplement, vitamins only, antioxidants only, or antioxidants excluding vitamins), type of outcome (cardiovascular death, angina, fatal or non-fatal myocardial infarction,
stroke, or transient
ischaemic attack), type of outcome in each supplement, type of study design (randomised, double blind, placebo controlled trial v open label, randomised controlled trial), methodological quality (high v low), duration of treatment (< 5 years v ≥ 5 years), funding source (pharmaceutical industry v independent organisation), provider of supplements (pharmaceutical industry v not pharmaceutical industry), type of control (placebo v no placebo), number of participants (≥ 10000 v < 10000), and supplements given singly or in combination
with other vitamin or antioxidant supplements by quality.
I was told as a medical student that «stress» had nothing to do
with ischaemic heart disease or
strokes.